Mela Angeliki, Goldman James E
Department of Pathology and Cell Biology, Columbia University, New York, New York 10032, USA.
J Neurosci. 2009 Sep 9;29(36):11172-81. doi: 10.1523/JNEUROSCI.3075-09.2009.
In the adult mammalian brain, oligodendrocyte progenitors can differentiate into mature oligodendrocytes during remyelination. Mechanisms that regulate migration and differentiation of progenitors are of great importance in understanding normal development and demyelinating/remyelinating conditions. In a microarray analysis comparing adult and neonatal O4-positive (+) cells, we found that the tetraspanin KAI1/CD82 is far more highly expressed in adult O4(+) cells than in neonatal O4(+) cells (Lin et al., 2009). CD82 is a metastasis suppressor, and its expression is often downregulated or lost in the advanced stages of metastatic cancer. We hypothesized that CD82 could be a factor that restricts migration and promotes differentiation of maturing oligodendrocytes. Western blot analysis of isolated adult O4(+) cells confirms the elevated levels of CD82, which continues to be expressed as these become O1(+) in vitro. In the adult rat white matter, CD82 is coexpressed with CC1 and olig2 but not with NG2 or GFAP. Immature cells of the neonatal forebrain subventricular zone (SVZ) infected in vivo with a retrovirus that constitutively expresses CD82 do not remain immature but differentiate into either CC1(+) and MBP(+) myelinating oligodendrocytes in the white matter or zebrinII(+) astrocytes in the cortex. Their migration from the SVZ is severely restricted. In contrast, downregulation of CD82 in SVZ cells in vivo, using retroviral-expressed short hairpin RNAs (shRNAs), prevents their differentiation into myelinating oligodendrocytes. shRNA-expressing cells remained PDGF receptor alpha positive, olig2(+), or NG2(+) or became CC1(+) nonmyelinating oligodendrocytes or GFAP(+) astrocytes. CD82 thus appears to be a critical molecule in the regulation of oligodendrocyte progenitor migration and myelination.
在成年哺乳动物大脑中,少突胶质前体细胞在髓鞘再生过程中可分化为成熟的少突胶质细胞。调节前体细胞迁移和分化的机制对于理解正常发育以及脱髓鞘/髓鞘再生情况至关重要。在一项比较成年和新生O4阳性(+)细胞的微阵列分析中,我们发现四跨膜蛋白KAI1/CD82在成年O4(+)细胞中的表达远高于新生O4(+)细胞(Lin等人,2009年)。CD82是一种转移抑制因子,其表达在转移性癌症晚期常下调或缺失。我们推测CD82可能是限制成熟少突胶质细胞迁移并促进其分化的一个因素。对分离出的成年O4(+)细胞进行的蛋白质免疫印迹分析证实了CD82水平的升高,在体外这些细胞转变为O1(+)时,CD82仍持续表达。在成年大鼠白质中,CD82与CC1和olig2共表达,但不与NG2或GFAP共表达。新生前脑脑室下区(SVZ)的未成熟细胞在体内被一种组成型表达CD82的逆转录病毒感染后,不会保持未成熟状态,而是分化为白质中CC1(+)和MBP(+)的髓鞘形成少突胶质细胞或皮质中zebrinII(+)的星形胶质细胞。它们从SVZ的迁移受到严重限制。相反,在体内利用逆转录病毒表达的短发夹RNA(shRNAs)下调SVZ细胞中的CD82,可阻止它们分化为髓鞘形成少突胶质细胞。表达shRNA的细胞仍为血小板衍生生长因子受体α阳性、olig2(+)或NG2(+),或者变为CC1(+)的无髓鞘少突胶质细胞或GFAP(+)的星形胶质细胞。因此,CD82似乎是调节少突胶质前体细胞迁移和髓鞘形成的关键分子。